SCHEMBL4726437

SCHEMBL4726437

O=c1oc2ccccc2cc1-c1cn2cc(Cl)ccc2n1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 10/20 0.71
NPC1 O15118 7/20 0.71
ALDH1A1 P00352 7/20 0.71
MAPT P10636 4/20 0.71
LMNA P02545 3/20 0.71
PKM P14618 1/20 0.71
POLB P06746 1/20 0.65
NFKB1 P19838 1/20 0.65
NFKB2 Q00653 1/20 0.65
RELA Q04206 1/20 0.65
TP53 P04637 6/20 0.57
KDM4E B2RXH2 5/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
HSD17B10 Q99714 2/20 0.57
MEN1 O00255 1/20 0.57
GAA P10253 1/20 0.57
HPGD P15428 1/20 0.57
TSHR P16473 1/20 0.57
KMT2A Q03164 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24335459 0.82 RAB9A (0.67) RAB9ANPC1ALDH1A1MAPTLMNA
SCHEMBL4713116 0.81 NPC1 (0.76) RAB9ANPC1ALDH1A1MAPTLMNA
SCHEMBL15066680 0.79 RAB9A (0.71) RAB9ANPC1ALDH1A1MAPTLMNA
SCHEMBL30708168 0.78 SUV39H2 (0.48) RAB9ANPC1ALDH1A1MAPTLMNA
SCHEMBL15069225 0.78 SUV39H2 (0.48) RAB9ANPC1ALDH1A1MAPTLMNA
SCHEMBL16669697 0.78 RAB9A (0.44) RAB9ANPC1ALDH1A1MAPTLMNA
SCHEMBL15068750 0.77 RAB9A (0.43) RAB9ANPC1ALDH1A1MAPTLMNA
SCHEMBL15068705 0.77 RAB9A (0.73) RAB9ANPC1ALDH1A1MAPTLMNA
SCHEMBL15068854 0.76 RAB9A (0.43) RAB9ANPC1ALDH1A1MAPTLMNA
SCHEMBL15069258 0.75 RAB9A (0.41) RAB9ANPC1ALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008029152-A2 TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY SUMMIT CORPORATION PLC (GB) 2008-03-13 WO disclosed